About ANI Pharmaceuticals Inc
- Industry: Pharmaceuticals
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.anipharmaceuticals.com/
Frequently Asked Questions
What is the 52-week range for ANIP?
The 52-week high is $97 and the 52-week low is $69.58.
What is the P/E ratio for ANIP?
The Price to Earnings (P/E) ratio is 15.47.
What is the dividend yield for ANIP?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is 19.64%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is 11.07%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 3.28.
Analyst Recommendation Trends
Wall Street analyst consensus for ANIP over the last few months:
Latest ANIP News
1 Small-Cap Stock for Long-Term Investors and 2 We Ignore
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.
ANI Pharmaceuticals Announces New Fluocinolone Acetonide Intravitreal Implant Data to be Presented at the American Academy of Ophthalmology 2026 Annual Meeting
Data from Phase 4 Open-Label, Single-Arm SYNCHRONICITY Trial will be presented in a late-breaking oral presentation during Uveitis Subspecialty Day 2026 Post-hoc analyses of baseline characteristics and efficacy outcomes in rescued and non-rescued patients from the Phase 4 NEW DAY trial will be presented in an on-demand ePoster PRINCETON, N.J., Sept. 30, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that data from SYNCHRONICITY, its Phase
3 Profitable Stocks Worth Investigating
Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.
Implied Volatility Surging for ANI Pharmaceuticals Stock Options
Investors need to pay close attention to ANIP stock based on the movements in the options market lately.
Ocular Therapeutix and ANI Pharmaceuticals Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after sentiment in the healthcare sector weakened, as the Centers for Medicare and Medicaid Services moved to cancel Affordable Care Act coverage for roughly 760,000 people and claw back billions in subsidies.
ANI Pharmaceuticals Announces the FDA Approval of Everolimus Tablets for Oral Suspension
PRINCETON, N.J., Sept. 23, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that it received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA), for Everolimus Tablets for Oral Suspension 2mg, 3mg and 5mg. ANI’s Everolimus Tablets for Oral Suspension are the generic version of the reference listed drug (RLD) Afinitor Disperz®. "The FDA approval of Everolimus Tablets for Suspension i
Oppenheimer Initiates Coverage On ANI Pharmaceuticals with Perform Rating, Announces Price Target of $85
Oppenheimer analyst Les Sulewski initiates coverage on ANI Pharmaceuticals (NASDAQ:ANIP) with a Perform rating and announces Price Target of $85.
ANI Pharmaceuticals Receives Final FDA Approval Of Its Abbreviated New Drug Application For Everolimus Tablets For Oral Suspension
Approval for Everolimus Tablets for Oral Suspension 2mg, 3mg and 5mg. ANI’s Everolimus Tablets for Oral Suspension are the generic version of the reference listed drug (RLD) Afinitor Disperz®."The FDA approval of
2 Cash-Producing Stocks to Target This Week and 1 We Avoid
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
ANI Pharmaceuticals, Inc. (ANIP) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
ANI Pharmaceuticals, Inc. (ANIP) Morgan Stanley 24th Annual Global Healthcare Conference September 14, 2026 7:00 AM EDTCompany ParticipantsNikhil Lalwani -...
ANI Pharmaceuticals (ANIP) Appoints Henry Gosebruch To Its Board
ANI Pharmaceuticals (NasdaqGM: ANIP) appointed biotechnology executive Henry Gosebruch to its Board of Directors. Gosebruch previously held leadership roles at Lakefront Biotherapeutics, Neumora Therapeutics, and AbbVie. Board member Muthusamy (Samy) Shanmugam resigned from the Board and will continue in key operational roles at ANI Pharmaceuticals. This kind of board refresh is not unique to ANI Pharmaceuticals, and investors who want broader exposure to companies shaped closely by their...
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-15 | Lalwani Nikhil | -5,400 | $71 | $383,400 |
| 2026-09-14 | Cook Meredith | -500 | $70.79 | $35,395 |
| 2026-09-11 | Thoma Jeanne | -1,000 | $71.53 | $71,530 |
| 2026-08-31 | CAREY STEPHEN P. | -2,850 | $72.8 | $207,480 |
| 2026-08-25 | Lalwani Nikhil | -5,400 | $74.3 | $401,220 |
| 2026-08-19 | Gosebruch Henry O | +6,662 | - | - |
| 2026-08-13 | Cook Meredith | -500 | $75.48 | $37,740 |
| 2026-08-10 | Gutwerg Ori | -3,162 | $77 | $243,474 |
| 2026-07-29 | CAREY STEPHEN P. | -2,850 | $81.36 | $231,876 |
| 2026-07-18 | Cook Meredith | -2,466 | $79.2 | $195,307 |
| 2026-07-13 | Cook Meredith | -500 | $81.84 | $40,920 |
| 2026-07-02 | CAREY STEPHEN P. | -3,313 | $49.51 | $164,027 |
| 2026-07-02 | CAREY STEPHEN P. | -3,313 | $86 | $284,918 |
| 2026-07-02 | CAREY STEPHEN P. | +3,313 | $49.51 | $164,027 |
| 2026-06-12 | Cook Meredith | -500 | $82.03 | $41,015 |
| 2026-06-08 | HAUGHEY THOMAS | -2,000 | $80.88 | $161,760 |
| 2026-06-05 | CAREY STEPHEN P. | -3,312 | $49.51 | $163,977 |
| 2026-06-05 | CAREY STEPHEN P. | -3,312 | $80 | $264,960 |
| 2026-06-05 | CAREY STEPHEN P. | +3,312 | $49.51 | $163,977 |
| 2026-05-21 | Thoma Jeanne | +4,357 | - | - |
| 2026-05-21 | Leonard Matthew J | +4,357 | - | - |
| 2026-05-21 | Pera Antonio R | +4,357 | - | - |
| 2026-05-21 | TANNENBAUM RENEE P | +4,357 | - | - |
| 2026-05-21 | HAUGHEY THOMAS | +4,357 | - | - |
| 2026-05-13 | Cook Meredith | -500 | $78.16 | $39,080 |
| 2026-05-13 | Walsh Patrick D | -10,000 | $80.63 | $806,300 |
| 2026-05-12 | Gutwerg Ori | -2,772 | $79.5 | $220,374 |
| 2026-05-12 | Rowland Thomas Andrew | -459 | $79.21 | $36,357 |
| 2026-05-11 | Lalwani Nikhil | -55,000 | $77.57 | $4,266,350 |
| 2026-05-11 | Walsh Patrick D | -3,973 | $80.75 | $320,820 |
| 2026-04-13 | Cook Meredith | -500 | $77.95 | $38,975 |
| 2026-03-13 | Cook Meredith | -500 | $72.62 | $36,310 |
| 2026-03-13 | Mutz Christopher | -3,162 | $71.64 | $226,526 |
| 2026-03-11 | Rowland Thomas Andrew | -4,772 | $74.91 | $357,471 |
| 2026-03-09 | Davis Krista | -5,087 | $74.13 | $377,099 |
| 2026-03-09 | Mutz Christopher | -3,602 | $74.18 | $267,196 |
| 2026-03-07 | Mutz Christopher | -3,314 | $74.04 | $245,369 |
| 2026-03-07 | Gutwerg Ori | -3,314 | $74.04 | $245,369 |
| 2026-03-07 | Lalwani Nikhil | -17,060 | $74.04 | $1,263,122 |
| 2026-03-07 | CAREY STEPHEN P. | -5,150 | $74.04 | $381,306 |
| 2026-03-06 | Davis Krista | -1,485 | $75 | $111,375 |
| 2026-03-06 | Mutz Christopher | -2,121 | $74.22 | $157,421 |
| 2026-03-05 | CAREY STEPHEN P. | -3,312 | $49.51 | $163,977 |
| 2026-03-05 | CAREY STEPHEN P. | -4,000 | $75.56 | $302,240 |
| 2026-03-05 | CAREY STEPHEN P. | -3,312 | $75.42 | $249,791 |
| 2026-03-05 | CAREY STEPHEN P. | +3,312 | $49.51 | $163,977 |
| 2026-03-03 | Gutwerg Ori | -2,060 | $76.5 | $157,590 |
| 2026-03-03 | Walsh Patrick D | -6,000 | $74.23 | $445,380 |
| 2026-03-02 | Mutz Christopher | -417 | $74 | $30,858 |
| 2026-02-28 | Davis Krista | -1,555 | $73.9 | $114,915 |
| 2026-02-28 | Cook Meredith | -1,555 | $73.9 | $114,915 |
| 2026-02-28 | Gassert Chad | -2,221 | $73.9 | $164,132 |
| 2026-02-28 | Mutz Christopher | -2,221 | $73.9 | $164,132 |
| 2026-02-28 | Gutwerg Ori | -2,221 | $73.9 | $164,132 |
| 2026-02-28 | Lalwani Nikhil | -12,217 | $73.9 | $902,836 |
| 2026-02-28 | CAREY STEPHEN P. | -2,773 | $73.9 | $204,925 |
| 2026-02-28 | Rowland Thomas Andrew | -628 | $73.9 | $46,409 |
| 2026-02-26 | Davis Krista | +10,810 | $77.15 | $833,992 |
| 2026-02-26 | Cook Meredith | +13,895 | $77.15 | $1,071,999 |
| 2026-02-26 | Gassert Chad | +11,116 | $77.15 | $857,599 |
| 2026-02-26 | Shanmugam Muthusamy | +11,116 | $77.15 | $857,599 |
| 2026-02-26 | Mutz Christopher | +21,306 | $77.15 | $1,643,758 |
| 2026-02-26 | Gutwerg Ori | +12,969 | $77.15 | $1,000,558 |
| 2026-02-26 | Lalwani Nikhil | +75,592 | $77.15 | $5,831,923 |
| 2026-02-26 | CAREY STEPHEN P. | +22,233 | $77.15 | $1,715,276 |
| 2026-02-26 | Rowland Thomas Andrew | +6,021 | $77.15 | $464,520 |
| 2026-02-20 | Davis Krista | -1,730 | $77.99 | $134,923 |
| 2026-02-20 | Mutz Christopher | -5,323 | $78.02 | $415,300 |
| 2026-02-19 | Davis Krista | -2,084 | $77.53 | $161,573 |
| 2026-02-14 | Davis Krista | -1,290 | $77.36 | $99,794 |
| 2026-02-14 | Cook Meredith | -1,779 | $77.36 | $137,623 |
| 2026-02-14 | Gassert Chad | -1,717 | $77.36 | $132,827 |
| 2026-02-14 | Mutz Christopher | -2,403 | $77.36 | $185,896 |
| 2026-02-14 | Gutwerg Ori | -1,888 | $77.36 | $146,056 |
| 2026-02-14 | Lalwani Nikhil | -10,298 | $77.36 | $796,653 |
| 2026-02-14 | CAREY STEPHEN P. | -2,448 | $77.36 | $189,377 |
| 2026-02-14 | Rowland Thomas Andrew | -485 | $77.36 | $37,520 |
| 2026-02-13 | Cook Meredith | -500 | $76.8 | $38,400 |
| 2026-02-12 | Davis Krista | -1,180 | $76.7 | $90,506 |
| 2026-02-12 | Cook Meredith | -1,534 | $76.7 | $117,658 |
| 2026-02-12 | Gassert Chad | -1,608 | $76.7 | $123,334 |
| 2026-02-12 | Mutz Christopher | -7,032 | $76.55 | $538,300 |
| 2026-02-12 | Mutz Christopher | -3,173 | $76.7 | $243,369 |
| 2026-02-12 | Gutwerg Ori | -1,775 | $76.7 | $136,143 |
| 2026-02-12 | Lalwani Nikhil | -11,688 | $76.7 | $896,470 |
| 2026-02-12 | CAREY STEPHEN P. | -2,829 | $76.7 | $216,984 |
| 2026-02-12 | Rowland Thomas Andrew | -566 | $76.7 | $43,412 |
| 2026-02-11 | Davis Krista | -3,017 | $76.25 | $230,046 |
| 2026-02-11 | Cook Meredith | -3,011 | $76.25 | $229,589 |
| 2026-02-11 | Gassert Chad | -4,269 | $76.25 | $325,511 |
| 2026-02-11 | Shanmugam Muthusamy | -2,898 | $76.25 | $220,973 |
| 2026-02-11 | Mutz Christopher | -4,546 | $76.25 | $346,633 |
| 2026-02-11 | Gutwerg Ori | -4,267 | $76.25 | $325,359 |
| 2026-02-11 | Lalwani Nikhil | -30,659 | $76.25 | $2,337,749 |
| 2026-02-11 | CAREY STEPHEN P. | -5,503 | $76.25 | $419,604 |
| 2026-02-11 | Rowland Thomas Andrew | -1,762 | $76.25 | $134,353 |
| 2026-01-13 | Cook Meredith | -500 | $84.33 | $42,165 |
| 2025-12-18 | Davis Krista | -1,622 | $82.4 | $133,653 |
| 2025-12-12 | Cook Meredith | -400 | $82.32 | $32,928 |
| 2025-12-05 | TANNENBAUM RENEE P | -1,800 | $81.15 | $146,070 |
| 2025-11-13 | Walsh Patrick D | -3,000 | - | - |
| 2025-11-13 | Walsh Patrick D | -8,643 | $86.88 | $750,904 |
| 2025-11-13 | Gassert Chad | -94 | $88 | $8,272 |
| 2025-11-13 | Cook Meredith | -400 | $87.27 | $34,908 |
| 2025-11-12 | Gassert Chad | -14,642 | $89.07 | $1,304,163 |
| 2025-10-13 | Cook Meredith | -400 | $90.09 | $36,036 |